Vaxart, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease)
Vaxart, Inc. (VXRT) reported Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) of 22.74 thousand shares for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease · last filed 2019-05-09
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, other share increase (decrease) for the quarter ending 2019-03-31 was 22.74K shares, a 65.86% decline year-over-year.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, other share increase (decrease) for the quarter ending 2018-12-31 was 38.23K shares.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, other share increase (decrease) for the quarter ending 2018-09-30 was 20.37K shares.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, other share increase (decrease) for the quarter ending 2018-06-30 was 143.95K shares.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, other share increase (decrease) for fiscal 2018 was 269.15K shares, a 1931.46% increase from fiscal 2017.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, other share increase (decrease) for fiscal 2017 was 13.25K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-03-31 | 22.74K shares 10-Q · filed 2019-05-09 | 60.96K shares derived: sum of 2 quarters · filed 2019-05-09 | 81.34K shares derived: sum of 3 quarters · filed 2019-05-09 | 225.29K shares derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-12-31 | 38.23K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | 58.60K shares derived: sum of 2 quarters · filed 2019-02-06 | 202.55K shares derived: sum of 3 quarters · filed 2019-02-06 | 269.15K shares 10-K · filed 2019-02-06 |
| 2018-09-30 | 20.37K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | 164.33K shares derived: sum of 2 quarters · filed 2018-11-13 | 230.92K shares 10-Q · filed 2018-11-13 | |
| 2018-06-30 | 143.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | 210.55K shares 10-Q · filed 2018-08-10 | ||
| 2018-03-31 | 66.60K shares 10-Q · filed 2018-05-15 | |||
| 2017-12-31 | 13.25K shares 10-K · filed 2019-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |